• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Hemcheck Sweden

Less than 1K followers
All
Press releases
ShowingAll content types

Regulatory press release13.11.2024 klo 16.15

Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider

Hemcheck Sweden
Regulatory press release12.02.2024 klo 14.50

Bio Vitos Pharma AB: KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer

Hemcheck Sweden
Regulatory press release20.12.2023 klo 08.30

Bio Vitos Pharma AB: The European Patent Office EPO grants patent that is important to Bio Vitos Pharma

Hemcheck Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release20.10.2023 klo 17.20

Hemcheck completes the transaction with Bio Vitos

Hemcheck Sweden
Regulatory press release15.05.2023 klo 16.20

Hemcheck has received a first order from its distributor Astemed

Hemcheck Sweden
Regulatory press release04.05.2023 klo 15.00

Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement

Hemcheck Sweden
Regulatory press release26.04.2023 klo 17.20

Hemcheck: Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)

Hemcheck Sweden
Regulatory press release05.04.2023 klo 23.50

Hemcheck has received a first order from the university hospital Charité in Berlin

Hemcheck Sweden
Regulatory press release16.03.2023 klo 14.10

Hemcheck: Additional agreement with Bio Vitos Medical brings forward the time for calling the extraordinary general meeting by one week

Hemcheck Sweden
Regulatory press release13.03.2023 klo 18.00

Hemcheck has received a first follow up order from its Finnish distributor

Hemcheck Sweden
Regulatory press release02.03.2023 klo 18.00

Hemcheck has received an additional follow up order from its UK distributor

Hemcheck Sweden
Regulatory press release28.02.2023 klo 22.15

Hemcheck receives follow up order from research program in the United States

Hemcheck Sweden
Regulatory press release03.02.2023 klo 17.30

Hemcheck has received a follow up order from its French distributor

Hemcheck Sweden
Regulatory press release01.02.2023 klo 15.30

Hemcheck has received a follow up order from its UK distributor

Hemcheck Sweden
Regulatory press release24.01.2023 klo 18.00

Hemcheck has received a first order from a leading hospital in Iceland

Hemcheck Sweden
Regulatory press release23.01.2023 klo 12.00

Hemcheck has received a follow up order from its Spanish distributor

Hemcheck Sweden
Regulatory press release16.01.2023 klo 23.30

Hemcheck has received another follow up order from its Irish distributor

Hemcheck Sweden
Regulatory press release03.01.2023 klo 18.27

Hemcheck extends agreement regarding previously communicated project with Region Skåne

Hemcheck Sweden
Regulatory press release20.12.2022 klo 11.00

Hemcheck has received a follow up order from its Irish distributor

Hemcheck Sweden
Regulatory press release12.12.2022 klo 16.00

Hemcheck has received an important order from a major OEM

Hemcheck Sweden